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Abstract
Background: Membrane-CD14 (mCD14) is expressed on the surface of monocytes, macrophages and
polymorphonuclear neutrophil leukocytes (PMN). mCD14 acts as a co-receptor along with Toll like receptor 4 (TLR
4) and MD-2 for the detection of lipopolysaccharide (LPS). However, studies using different sample preparation
methods and anticoagulants have reported different levels of mCD14 on the surface of monocytes and
neutrophils. In this study, the influence of various anticoagulants and processing methods on measurement of
mCD14 on monocytes and neutrophils was examined.
Results: Whole blood samples were collected in vacutainer tubes containing either sodium heparin (HEPARIN),
ethylenediaminetetraacetic acid (EDTA) or sodium citrate (CITRATE). mCD14 on neutrophils and monocytes in
whole blood samples or isolated cells was measured by the method of flow cytometry using fluorescein
isothiocyanate (FITC)-labeled monoclonal antibody. There was a significant difference (p < 0.05) in the mean
channel fluorescence intensity (MFI) of mCD14 on neutrophils in whole blood samples anticoagulated with
HEPARIN (MFI = 64.77) in comparison with those in whole blood samples anticoagulated with either EDTA (MFI =
38.25) or CITRATE (MFI = 43.7). The MFI of mCD14 on monocytes in whole blood samples anticoagulted with
HEPARIN (MFI = 206.90) was significantly higher than the MFI in whole blood samples anticoagulated with EDTA
(MFI = 149.37) but similar to that with CITRATE (MFI = 162.55). There was no significant difference in the
percentage of whole blood neutrophils or monocytes expressing mCD14 irrespective of type of anticoagulant
used. However, MFI of mCD14 on monocytes was about 3.2-folds (HEPARIN), 3.9-folds (EDTA) or 3.7 folds (CITRATE)
higher than those on neutrophils. Furthermore, there was no significant difference in mCD14 levels between
unprocessed whole blood monocytes and monocytes in peripheral blood mononuclear cell preparation.
Conversely, a highly significant difference was observed in mCD14 between unprocessed whole blood neutrophils
and isolated neutrophils (p < 0.05).
Conclusion: From these results, it is suggested that sodium heparin should be the preferred anticoagulant for use
in the reliable quantification of the surface expression of mCD14. Furthermore, measurement of mCD14 is best
carried out in whole blood samples, both for neutrophils and monocytes.
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Background
Membrane CD14 (mCD14) is a membrane-associated
glycosylphosphatidylinositol (GPI)-linked receptor pro-
tein [1]. It is constitutively expressed on the surface of
various cells, including monocytes, macrophages and
neutrophils. CD14 is a high affinity receptor protein for
the complexes of bacterial lipopolysaccharide (LPS) and
LPS-binding protein [2]. In addition to its membrane-
expressed form, CD14 can also be found in blood and
milk as soluble CD14 (sCD14) [3,4]. Both membrane
and soluble forms of CD14 bind to Gram-negative bac-
teria [5]. It has also been demonstrated that CD14 is
capable of binding with other bacterial and yeast cell
wall components [6] and because of this multiple identi-
fication, CD14 is referred to as a “pattern recognition
receptor” [7]. In addition, CD14 works in combination
with Toll-like receptors, members of the interleukin
family, for the transmission of intracellular signals. For
example, CD14 acts as a co-receptor along with Toll
like receptor 4 (TLR 4) and MD-2 for the detection of
LPS [8,9].
Both neutrophils and monocytes/macrophages are
important to combat invading bacteria. At the site of
infection, phagocytes (predominantly granulocytes and
monocytes/macrophages) destroy Gram-negative bac-
teria by phagocytosis, mostly through the LPS receptor,
CD14 on the cell surface [10]. However, there are some
discrepancies in the reported levels of mCD14 expres-
sion on the surface of monocytes and neutrophils (Table
1). These reports employed different sample preparation
methods and blood anticoagulants [11-14] which could
have affected the results. Anticoagulation is achieved
either by the binding of calcium ions (EDTA and
citrate) or by the inhibition of thrombin (heparin).
Heparin is the preferred anticoagulant for most clinical
chemistry analyses and for the measurement of some
trace elements, ammonia, blood pH and blood gas ana-
lysis [15]. EDTA is particularly useful for hematological
examination. On the other hand, sodium citrate solution
is widely used for coagulation studies because the effect
is easily reversible by the addition of Ca + 2 (calcium
ions). However, these commonly used anticoagulants
have been reported to have varying effects on blood
components [16,17]. Therefore, blood handling and the
choice of anticoagulant may have an effect on the qual-
ity of data and potentially result in analytical bias.
Little is known about the influence of sample handling
and the various types of commonly used anticoagulants
in relation to the quantification of mCD14 on mono-
cytes and neutrophils in bovine.
The aim of this study therefore was to investigate the
effects of anticoagulants and cell preparation procedures




Eighteen mid- to late-lactating Holstein cows (220 ± 60
d of lactation) were randomly selected for this study.
The cows were in their first to third parties. The
monthly assessment of farm records (individual cows)
indicated that the animals were in general good health.
The cows were individually housed, during the entire
experimental period in identical stalls with sawdust as
bedding, had ad libitum access to drinking water and
were fed the standard farm rations for their physiologi-
cal stages. This study was approved by the McGill Uni-
versity Animal Care Committee.
Blood sampling
Blood was collected aseptically from the caudal vein by
venipuncture into one of three vacutainer tubes contain-
ing either sodium heparin (HEPARIN), sodium citrate
(CITRATE) or ethylenediaminetetraacetic acid (EDTA)
(Becton Dickinson, Franklin Lakes, NJ, USA). These
tubes were immediately placed on ice and samples were
prepared or analyzed within 45 minutes of collection.
Isolation of polymorphonuclear neutrophil leukocytes
(PMN)
Eight millilitres of whole blood was aseptically collected
in vacutainer tubes containing either HEPARIN,
CITRATE or EDTA and immediately placed on ice. The
PMN was isolated from whole blood according to an
Table 1 Effects of different isolation methods on the percentage of PMN or monocytes expressing mCD14 in different
species
Source Percentage of PMN expressing mCD14 Percentage of monocytes expressing mCD14 Method Authors
Human ND 90 Whole blood [18]
Goat 47.2 2.60 Isolated cells [19]
Ilama 45.23 13.58 Isolated cells [19]
Rabbit 34.63 4.24 Whole blood [19]
Bovine 40-95 60-95 Whole blood [20]
Bovine 35.6 ND Isolated cells [21]
ND: Not determined
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established protocol in our laboratory [22]. The cell pel-
let was washed twice with 1 × DPBS (Dulbecco’s phos-
phate buffered saline) by subsequent centrifugation at
250 × g for 5 minutes at 4°C. The cell pellet was resus-
pended in 1 mL of 1 × DPBS and kept on ice. Live cells
were counted by using a haemacytometer and the try-
pan blue exclusion method. The cells showed 95% viabi-
lity. Cells were adjusted to a concentration of 1.0 × 106
viable PMN/mL.
Isolation of peripheral blood mononuclear cells (PBMC)
Bovine peripheral blood mononuclear cells (PBMC)
were isolated from whole blood preparations of healthy
cows by the use of density gradient centrifugation over
Ficoll-Paque (density 1.077; Amersham Biosciences, NJ,
USA). PBMC were isolated with some slight modifica-
tions as described by Weiss et al. [23]. All solutions and
equipment coming into contact with the cells were steri-
lized and the whole process was performed under sterile
conditions. Briefly, 7 mL of whole blood samples were
diluted 1:1 (v/v) with 7 mL of 1 × DPBS. The resulting
solution was carefully overlayed on 20 mL of Ficoll-
Paque solution. The tube was centrifuged at 400 × g for
40 minutes at room temperature to separate mononuc-
lear cells from other fractions. Cells from the interface
(PBMC) were removed and placed in a 50 mL clean
sterilized falcon tube. Tubes were then filled with ice-
cold 1 × DPBS and centrifuged at 400 × g at 4°C. The
resulting pellet from the centrifugation was resuspended
in 1 × DPBS and washed twice by centrifugation for 8
minutes at 400 × g. After these wash steps, the pellet
was resuspended in 1 × DPBS and adjusted to a concen-
tration of 1.0 × 106 cells/mL.
Further isolation of monocytes from PBMC could be
achieved by adhesion or positive and negative immuno-
selection but these procedures are laborious and time-
consuming. Thus, further isolation was not carried out
in this study to avoid additional effect of the lengthy
procedure.
Multiparametric flow cytometry
Flow cytometry was used to study the influence of the
different anticoagulants on mCD14 on monocytes and
neutrophils in healthy cows. For the assay using whole
blood samples, 200 μL of whole blood was placed in a
12 × 75 mm flow cytometric (FCM) tube and incubated
with 10 μL of fluorescein isothiocyanate (FITC)-labeled
mouse anti human CD14 antibody (ABD Serotec Inc.
Raleigh, NC, USA). This was mixed thoroughly and
incubated at room temperature on an orbitron rotator
(Boekel Ind. Inc., PA, USA) for 30 minutes. Lysis of ery-
throcytes was performed by adding 2 ml of a lysing
solution (0.87% Tris buffered ammonium chloride solu-
tion (NH4CL)) to the mixture. This was mixed gently
and incubated on an orbitron rotator at room tempera-
ture and centrifuged at 250 × g for five minutes at 4°C.
The supernatant was aspirated leaving approximately
400 μL of cells in the FCM tube. This was washed with
3 mL of ice-cold 1 × DPBS, pH 7.2 (Invitrogen) by cen-
trifuging at 250 × g for 5 minutes at 4°C. The superna-
tant was aspirated as described above and the cells
resuspended in 400 μL of ice-cold 1 × DPBS. The cells
were then washed by centrifugation and fixed with 2%
DPBS-buffered paraformaldehyde and analysed within
60 minutes with a BD FACSCalibur (Becton Dickinson
Immunocytometry Systems, San José, CA, USA). The
FACSCalibur was equipped with an air-cooled argon ion
laser (488 nm, 15 mW) and a diode laser (635 nm, 9
mW). This standard instrument is equipped with two
light scatter detectors that measure forward and side
scatter and four fluorescence detectors that detect
appropriately filtered light at 525 nm.
Excitation of samples was at 488 nm, with FITC
fluorescence measured at 525 nm ± 10 nm. Acquisi-
tion was stopped when 30,000 gated events per sample
were collected. Gating of monocytes and PMN was
based on forward side scatter and side scatter dot
plots. All parameters were recorded with the logarith-
mic amplifications. The data analysis was performed
using Cell-Quest Software (Becton Dickinson). List
mode flow cytometric data from 30,000 events were
stored and processed with the Windows Multiple
Document Interface for Flow Cytometry (WinMDI)
software version 2.8 (Joseph Trotter, The Scripps
Research Institute, http://facs.scripps.edu/software.
html). The software constructs a histogram of fluores-
cence distribution and the relative mean fluorescence
intensity (MFI) was obtained and expressed as an
index of surface expression. The control was a FITC-
conjugated immunoglobulin of the relevant isotype
(ABD Serotec Inc., Raleigh, NC, USA).
Multiparametric flow cytometry for isolated cells
Isolated cells, about 1.0 × 106 cells/mL, were similarly
analyzed as detailed out in the previous section. Isolated
cells were placed in a 12 × 75 mm FCM tube and incu-
bated with 10 μL of fluorescein isothiocyanate (FITC)-
labeled mouse anti human CD14 antibody (ABD Serotec
Inc. Raleigh, NC, USA). This was mixed thoroughly and
incubated at room temperature on an orbitron rotator
(Boekel Ind. Inc., PA, USA) for 30 minutes. Cells were
later washed twice with 3 mL of 1 × DPBS by centrifu-
ging at 250 × g for five minutes at 4°C. The cells were
then washed by centrifugation with 1 × DPBS and fixed
with 2% DPBS-buffered paraformaldehyde and analysed
within 60 minutes with a BD FACSCalibur (Becton
Dickinson Immunocytometry Systems, San José, CA,
USA). Monocyte and neutrophil populations were
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identified by their light scatter properties as the side
scatter and the forward scatter on dot plots.
Statistical analysis
Flow cytometric data (percent fluorescence and MFI)
were analysed as a one way ANOVA using the MIXED
procedures of SAS version 6.1 program [24]. Treatment
means were separated using the least square means
option of SAS. Differences between treatment means
were tested using the Scheffe’s Multiple Comparison
test. Statistical significance was declared at P ≤ 0.05.
Statistical model used : Yij = µ + anticoagulanti + eij
Results
Effects of different anticoagulants on mCD14 on
neutrophils
The effect of different commonly used anticoagulants on
the surface expression of bovine mCD14 on neutrophils
was first investigated on whole blood samples. There
was no significant difference in the percentage of PMN
expressing mCD14 among the different anticoagulants
used with a mean of 94.85%, 94.42%, and 94.70% for
HEPARIN, CITRATE and EDTA respectively (Figure
1A). However, when the density of mCD14 on neutro-
phils was compared, HEPARIN, with a MFI of 64.77
was significantly different (p < 0.05) from CITRATE
(43.70) and EDTA (38.25) anticoagulated blood samples
(Figure 1B).
Effects of using different anticoagulants on the
expression of mCD14 on monocytes
Similarly, the effect of different commonly used anticoa-
gulants on the surface expression of bovine mCD14 on
monocytes was investigated in whole blood samples.
There was no significant difference in the percentages of
monocytes expressing mCD14 among the three groups
(Figure 2A). However, when the MFI was compared, the
HEPARIN group with a MFI of 206.90 was significantly
higher than the EDTA group with a MFI of 149.37 but
was not significantly different from the CITRATE group
with a MFI of 162.55 (Figure 2B). In addition, there was
no significant difference between CITRATE and EDTA
anticoagulated blood.
Effects of isolation procedures on the expression of
mCD14 on neutrophils
In order to determine whether sample preparation
affected the quantification of mCD14, mCD14 on whole
blood or isolated leukocytes was determined. Samples
used were anticoagulated with HEPARIN only. There
was a significant difference in the percentage of PMN
expressing mCD14 (Figure 3A) which drastically
reduced from 97.97% observed in whole blood neutro-
phils to 24.82% in isolated neutrophils. Furthermore,
whole blood neutrophils recorded a higher number of
mCD14 molecules as measured by the MFI of 60.70 on
their surfaces, which was significantly different from iso-
lated neutrophils, 33.27 (Figure 3B).
Effects of isolation procedures on the expression of
mCD14 on monocytes
In contrast to neutrophils, the percentages of whole
blood monocytes (84.89%) expressing mCD14 on their
surfaces (anticoagulated with HEPARIN) and monocytes
from isolated PBMC (82.34%) (blood was anticoagulated
with HEPARIN) were not significantly different (Figure
4A). Likewise, the MFI of whole blood monocytes
(228.48) did not change significantly when compared to
monocytes in isolated PBMC (225.15) (Figure 4B).
Discussion
Blood collection and sometimes isolation of immune
cells are necessary for the measurement of blood
immune parameters ex-vivo. Anticoagulatants prevent
blood clotting before analysis of samples. In this study,
flow cytometry was used to determine mCD14
Figure 1 Impact of different blood anticoagulants on the surface expression of CD14 on bovine neutrophils. Whole blood samples
obtained from 18 Holstein cows were anticoagulated with: sodium heparin (HEPARIN), sodium citrate (CITRATE) and ethylenediaminetetraacetic
acid (EDTA). The percentage of PMN expressing mCD14 (1A) and the mean channel fluorescence intensity (MFI) (1B) was measured. Results for
each treatment are the mean from 6 cows. Treatment means with different superscripts are significantly different (p < 0.05) using Scheffe’s
multiple comparison test.
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expression on whole blood neutrophils and monocytes
as well as on isolated monocytes and neutrophils from
blood samples collected into tubes containing different
anticoagulants. Our study establishes that both anticoa-
gulant and processing method has an effect on the levels
of mCD14 on bovine cells.
In this study, we show that sodium heparin is the pre-
ferred choice of anticoagulant to use in the quantifica-
tion of mCD14 on neutrophils and monocytes.
Although the number of cells expressing mCD14,
whether monocytes or neutrophils, was the same irre-
spective of type of anticoagulant in our study, the den-
sity of mCD14 was significantly higher on cells from
samples anticoagulated in heparin than in CITRATE
and EDTA (Figures 1B and 2B). Our results are similar
to the findings of Harding et al. [25] who reported a sig-
nificantly higher platelet-monocyte aggregation level in
blood anticoagulated with heparin as compared to D-
Phenylalanine-L-prolyl-L-arginine chloromethyl ketone
(PPACK), sodium citrate or EDTA. Similarly, Walter et
al. [26] observed that levels of bioactive TGF-beta in
blood collected into heparin but not EDTA tubes
remained stable for longer periods (up to 18 h), even
when kept at room temperature. Therefore, they recom-
mended that heparin should be the choice anticoagulant
when reliable estimates of TFG-beta are needed.
Heparin is a naturally-occurring anticoagulant produced
by basophils and mast cells of mammals. It prevents the
formation of clots and extension of existing clots within
blood through the inhibition of thrombin and is gener-
ally recommended as the suitable anticoagulant for
plasma biochemical measurements [15]. Heparin has the
advantage over EDTA of not affecting the levels of most
ions in blood. However, heparin must be used with cau-
tion because it has been shown that the levels of ionized
calcium may be decreased if the concentration of
heparin in the blood specimen is too high [27]. The dif-
ferent effects of anticoagulant and isolation procedure
on levels of mCD14 could be mostly due to shedding of
mCD14 from cell surface. It has been shown that under
certain conditions monocytes/macrophages can remove
cell-bound IgG without destroying the opsonised cell
[28]. A recent study [29] showed that this mechanism
accounts for a phenomenon called ‘shaving’, where
monocytes can remove anti-CD20 antibodies together
with CD20 from the surface of antibody-coated target
cells. This process occurs through an endocytic reaction
called trogocytosis that depends on Fcc receptor I
expression on the acceptor cell [29]. When this happens,
the shaved target cells are viable but have reduced CD20
Figure 2 Impact of different blood anticoagulants on the surface expression of mCD14 on bovine monocytes. Whole blood samples
obtained from 18 Holstein cows were anticoagulated with: sodium heparin (HEPARIN), sodium citrate (CITRATE) and ethylenediaminetetraacetic
acid (EDTA). The percentage of monocytes expressing mCD14 (2A) and the mean channel fluorescence intensity (MFI) (2B) was measured.
Results for each treatment are the mean from 6 cows. Treatment means with different superscripts are significantly different using Scheffe’s
multiple comparison tests.
Figure 3 Effect of the isolation procedure on the surface expression of CD14 on neutrophils. Whole blood or isolated neutrophil was
stained with CD14 mAb. Blood was anticoagulated with HEPARIN. Using flow cytometry, the percentage of PMN expressing mCD14 (3A) and
the mean channel fluorescence intensity (MFI) (3B) was measured. Results for each treatment are the mean from 5 cows. Treatment means with
different letters are significantly different (p < 0.05) using Scheffe’s multiple comparison tests.
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expression [30]. Furthermore, Pedersen et al. [31]
demonstrated that a monocyte-mediated shaving reac-
tion can lead to complete loss of most anti-CD20 anti-
bodies from the surface of B cells. The effect of
shedding observed in our study could be explained by
this mechanism of shaving. Our results showed a more
pronounced effect of EDTA and CITRATE on the shed-
ding of mCD14 in comparison with heparin. Both
EDTA and CITRATE are calcium chelators and might
be involved in other divalent cation-dependent interac-
tions which may interfere with other processes thus
leading to the much lower levels of mCD14 on mono-
cytes and neutrophils [12]. Sarma et al. [32] have
demonstrated that cation chelation with EDTA mark-
edly reduces platelet-leukocyte interactions in vitro.
Also, a reduction in platelet-neutrophil binding with
EDTA and citrate has been demonstrated [25,33]. These
could further explain the significantly lower density of
mCD14 on the surface of monocytes and neutrophils in
blood anticoagulated with the calcium chelators, EDTA
and CITRATE.
By comparing the mCD14 levels on leukocytes in
whole blood and after Ficoll-Paque density gradient
isolation, we showed that the isolation procedure had
no effect on the number of monocytes expressing
mCD14 but had a drastic effect on the number of neu-
trophils expressing mCD14. Human monocytes
expressed about 99,500-134,600 CD14 molecules on
their surfaces and human neutrophils about 1,900-
4,400 [11]. In a recent study, these differences were
confirmed in bovine cells by Ibeagha-Awemu et al.
[20] who recorded monocytes in a zone of higher
expression of CD14 on histograms of flow cytometric
data while more neutrophils were recorded in a region
of lower expression. Their study also demonstrated a
higher density of mCD14 on monocytes (MFI =
201.44) than neutrophils (MFI = 34.76) in blood. Thus,
the dramatic effect of isolation procedure on neutro-
phils could be explained by their generally lower num-
bers and also the lower density of mCD14 molecules
on their surfaces as compared to monocytes, which
resulted in a pronounced effect of shedding. Other
authors have also demonstrated the effect of isolation
procedure on neutrophil shedding of mCD14 mole-
cules [21,34].
Our results of similar percentages of PMN or mono-
cytes expressing mCD14 regardless of type of anticoagu-
lant used in whole blood is supported by the findings of
Ibeagha-Awemu et al. [20]. The positive results with
unprocessed whole blood, apart from saving time and
material also allow the measurement of these para-
meters in a smaller volume of blood. Furthermore, the
use of whole blood is simple, fast, requires less handling
steps and minimal complex procedures. Conversely, the
processes of cell isolation does not only lead to unreli-
able estimates but the process can be laborious, time
consuming, require complex steps and larger starting
material and can also be costly.
Conclusion
In summary, we propose that reliable mCD14 measure-
ments in blood should be obtained by using freshly
obtained whole blood as starting material and heparin
as blood anticoagulant. Our findings have provided
important methodological information that should be
considered in the reliable estimation of the mCD14 pro-
tein, a crucial molecule that contributes to host innate
recognition of bacterial cell wall components.
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